Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes
Authors' conclusion
Overall, improvements in glycaemia in young adults were achieved with greater accessibility to subsidised diabetes technologies.
Study context
- Population
- Young adults with T1D aged 15–25 years attending a young adult diabetes clinic in Sydney, Australia, July 2019–June 2024
- Participants
- 418 adults
- Outcome
- Change in glycaemia as measured by HbA1c
- Follow-up
- Across 5 years
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
Median HbA1c
- Median HbA1c improved from 68 mmol/mol (8.4%) to 64 mmol/mol (8.0%)
- p < 0.001
Observational data: associations, not effects.
Further findings
Continuous glucose monitors (CGM) use · over the study duration
- CGM use increased from 29.4% to 76.2%; uptake increased in all sociodemographic groups
Insulin pump use
- Insulin pump use remained unchanged (52-57%); increase only in lowest sociodemographic cohort, reduction in middle socio-economic groups
Hybrid closed loop (HCL) insulin pump use
- HCL use increased from 5.1% to 35.4%
- CGM and HCL demonstrated independent benefits to glycaemia
Safety
- Severe hypoglycaemia rate
- 1.08/100 person-years
- DKA rate
- 4.90/100 person-years
- Pump therapy was associated with reduced DKA
Original publication
Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes. Diabet Med. Published 17 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →